ADT in prostate cancer increases diabetes and fractures, but not MI

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1261, 2009-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 4, 2017-11 ,pp. : 276-284

Bentham Science Publishers

Access to resources Recommend Favorite

Leuprorelin increases bodyfat in men with prostate cancer

By  

Inpharma, Vol. 1, Iss. 1330, 2002-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Prostate Cancer, miRNAs, Metallothioneins and Resistance to Cytostatic Drugs

By  

Current Medicinal Chemistry, Vol. 20, Iss. 4, 2013-02 ,pp. : 534-544

Bentham Science Publishers

Access to resources Recommend Favorite

FLt3 ligand increases dendritic cell count in prostate cancer

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Pomegranate juice significantly increases prostate specific antigen (PSA) doubling time in patients with prostate cancer and rising PSA levels

By  

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite